VEGFR3(FLT4) Kinase Assay Kit

Catalog #
79738
$535 *
Size: 96 reactions
Qty
*US Pricing only. For international pricing, please contact your local distributor.
Purchase
Description

The VEGFR3 Kinase Assay Kit is designed to measure VEGFR3 kinase activity for screening and profiling applications using ADP-Glo® Kinase Assay as a detection reagent.

This product has been cited 1 time.

Synonyms
Vascular Endothelial Growth Factor Receptor 3, Fms Related Tyrosine Kinase 4, Tyrosine-Protein Kinase Receptor FLT4, Fms-Like Tyrosine Kinase 4, EC 2.7.10.1
Product Info
Storage and Usage
Citations1
Assay Kit Format
Luminescent
Supplied As
The VEGFR3 Kinase Assay Kit comes in a convenient 96-well format, with enough purified recombinant VEGFR3 enzyme, VEGFR3 substrate, ATP, and kinase assay buffer for 100 enzyme reactions.
Materials Required But Not Supplied

ADP-Glo® Kinase Assay (Promega #V6930)
Dithiothreitol (DTT, 1 M; optional)
Microplate reader capable of reading luminescence
Adjustable micropipettor and sterile tips
30°C incubator

Format

Assay Kit Components

UniProt #
P35916
Background
Vascular endothelial growth factor receptor 3 (VEGFR3), also called Fms-Related Tyrosine Kinase 4 (FLT4), is a tyrosine kinase (TK) receptor for VEGFs that plays a central role in tumor angiogenesis; therefore, the inhibition of VEGFR3 is a promising therapeutic strategy for inhibiting angiogenesis and tumor growth.
References

Yeh, Yu-Wen et al. “Targeting the VEGF-C/VEGFR3 axis suppresses Slug-mediated
cancer metastasis and stemness via inhibition of KRAS/YAP1 signaling” Oncotarget vol.
8,3 (2016): 5603-5618.


Silvia M. Ferrari, et al. “Lenvatinib in the Therapy of Aggressive Thyroid Cancer: State of
the Art and New Perspectives with Patents Recently Applied”, Recent Patents on Anti-
Cancer Drug Discovery (2018) 13: 201.